Monograph
C01CA04 - Dopamine |
Not porphyrinogenic |
NP |
Rationale
Endogenous substance. Non-CYP metabolism. No data pointing to CYP-interaction.
Therapeutic characteristics
Endogenous signal substance liberating noradrenaline. Used in shock due to its inotropic effect on heart minute volume.
Metabolism and pharmacokinetics
Metabolized by monoamine oxidase and COMT, primarily in the liver.
Personal communication
Stig Thunnel 2004: Used in Swedish porphyria ward.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Scientific articles | |
| 1. | Guideline for application of anesthesia in patients with porphyria. [German]. Anasthesiologie und Intensivmedizin 2002; 43(7-8):485-488.
Bohrer H, Olthoff D, Roewer N, Schulte am Esch HCJ. |
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Dopaminehydrochloride · Neoatricon 
Neoatricon 
Dopamina 
Clorhidrat Dopamina 
Dopamine · Dopamine hydrochloride 
Dopmin · Neoatricon 
Dopamin 
Dopaminum · Neoatricon 
Dopamin 
Neoatricon 
Dopmin · Neoatricon 
Neoatricon
© NAPOS 2025